Perform all activities related to investigation of customer complaints, process return samples for credit and reconcile call center complaints. Ensure on-time closure of complaint records and tasks associated with data requests from other departments. Identify critical complaints and prioritize these investigations to meet reporting requirements. Monitor complaint activity for trends and conduct trend investigations as appropriate. Generate and report metrics for monthly Council meetings, quarterly status meetings and annual product reviews. Participate and support in all team activities and projects as assigned.
Candidate must have a Science degree, a background in the Pharmaceutical Industry and 3-5 years’
experience in the processing customer complaints. Must be computer literate and have good written and
verbal communication skills; data entry experience and familiarity with TrackWise software or
comparable system is a plus. Must be detail-oriented to assure accuracy of completed tasks, and have
the ability to work independently or in a team setting. Must be able to manage multiple tasks at a time
and shift focus from one priority to another seamlessly.
Strong sense of ownership and accountability.
Office environment.
Light lifting of file boxes.

Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. We are committed to developing and offering pharmaceutical products that meaningfully benefit patients, with a commitment to advancing patient care through transdermal drug delivery.
Over 300 Noven colleagues are working to advance our business and benefit patients at locations in Miami, FL, Jersey City, NJ. We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches, and we serve as Hisamitsu's growth platform for U.S. prescription pharmaceuticals.
Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances.